Industry litigation – Page 12
-
Business
US senators examine agrochem consolidation
Judiciary committee voices concern over pending merger deals
-
Business
Sanofi sues Merck & Co over biosimilars
Merck challenges insulin patents, but Sanofi claims infringement
-
Business
US government sued over merger crackdown
Business groups challenge Obama’s steps to limit tax inversions
-
Business
Rohm and Haas fined for safety violations
Fines relate to a trimethylaluminium explosion that injured four in January
-
Business
Former Lotte Chemical chief under fire
Ex-head of South Korean firm grilled by prosecutors over alleged fake accounting records
-
Business
Juno CAR-T trial suspended after patient deaths
Immunotherapy study restarted with amended pre-treatment protocol
-
Business
DuPont found liable in second of 3400 cancer cases
US jury awards over $5 million in claim linked to PFOA emitted by DuPont plant
-
Business
Brexit uncertainty ripples across regulation
What might leaving the EU mean for medicines regulation, the Unified Patent Court, and the UK’s participation in Reach?
-
Business
Unpicking doctor payments
Accepting even small meals from drug industry reps appears to influence doctors’ prescription rates
-
Business
Lies and deception see Astellas UK suspended by trade body
Company promoted drugs inappropriately and misled regulators in the resulting investigation
-
Business
Harvard settles with ex-student over drug royalties
Student claimed university forced him to accept unfair cut in patent deal
-
Business
US biotech director accused of insider trading
Biostatistics chief at Akebia charged with securities fraud
-
Business
Metals boss admits illegal export plot
Global Metallurgy chief conspired to export restricted metals to Iran
-
Business
Judge voids Merck & Co’s $200m patent claim
‘Serious misconduct’ kills case over Gilead’s hepatitis C drugs
-
Business
Vertellus enters bankruptcy
Chemical maker files for Chapter 11 bankruptcy protection for its US operations and plans to auction the business
-
Business
India hit hard by US regulatory sanctions
Data integrity issues have led to punitive measures, but companies are taking measures to improve
-
Business
US tax relief law benefits chemical makers
Bill provides mechanism to waive import tariffs on materials not available from domestic suppliers
-
Business
Deadly US fertiliser plant blast was deliberately set
Fire that caused West Fertilizer explosion was a ‘criminal act,’ US agency concludes
-
Business
Daiichi Sankyo awarded damages from former Ranbaxy owners
Arbitration says Singh family withheld information about regulatory investigations during Ranbaxy takeover
-
Business
US treasury rules scupper Pfizer–Allergan merger
Government aims to crack down on corporate tax avoidance through ‘inversion’ deals